3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
2
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Genitourinary
2
Thoracic
1
Sarcoma
1
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
Breast
1
Conditions
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Sarcoma
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Lung Neoplasms
1
Liver Neoplasms
1
Head and Neck Neoplasms
1
Colonic Neoplasms
1
Breast Neoplasms
1
Anus Neoplasms
1
Interventions
Magnetic Resonance Spectroscopy
81
Specimen Handling
80
Cyclophosphamide
72
pembrolizumab
61
Nivolumab
53
Radiotherapy
52
fludarabine
43
Cisplatin
42
Biopsy
40
Carboplatin
38
Standard of Care
35
Dexamethasone
31
Radiation
30
Bevacizumab
30
Rituximab
29
Surveys and Questionnaires
27
Radiosurgery
26
Doxorubicin
26
Temozolomide
25
Gemcitabine
25
Cytarabine
25
Blood Specimen Collection
25
venetoclax
24
Practice Guidelines as Topic
24
Paclitaxel
24
fludarabine phosphate
23
Ipilimumab
21
atezolizumab
20
Vincristine
20
Interviews as Topic
20
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER
×
Radionuclide Imaging
×
30 days
×
Clear all
NCT06003556
2026-06-03
P-GAP
University of Alberta
Phase 2
Recruiting
138 enrolled
NCT06904365
2026-05-18
OvAR-Y
Washington University School of Medicine
Active not recruiting
10 enrolled